Table 1 Characterisation of clinical material (A) and primary antibodies used for immunohistochemistry (IHC) (B)

From: Differential expression of ANXA6, HSP27, PRDX2, NCF2, and TPM4 during uterine cervix carcinogenesis: diagnostic and prognostic value

(A)

Diagnosis, FIGO

Histopathology

Abbrevation

Number of cases (%)

Normal cervix

Normal cervix

SCE

8 (11.94)

CIN 2

Moderate cervical intraepithelial dysplasia

CIN 2

4 (5.97)

CIN 3

Severe cervical intraepithelial dysplasia

CIN 3

9 (13.43)

 

Squamous cervical carcinoma in situ

 

12 (17.91)

SCC, stage IA1

Microinvasion <3 mm in depth and <7 mm horizontally

MicSCC

7 (10.45)

SCC, stage IA2

Invasion >5 mm in depth or >7 mm horizontally

InvSCC

2 (2.99)

SCC, stage IB1

Visible lesion ≤4 cm in greatest dimension

 

17 (25.37)

SCC, stage IB2

Visible lesion >4 cm

 

2 (2.99)

SCC, stage IIA

Without parametrial invasion, but involvimg upper 2/3 of vagina

 

1 (1.49)

SCC, stage IIB

With parametrial invasion

 

1 (1.49)

SCC, stage III

Extends to pelvic wall or lower third of vagina

 

3 (4.48)

Total

  

66

(B)

Protein

Antibody

Origin

Clone

Epitope detection

Dilution factor

Tissues for positive controls

Manufacturer

ANXA6

Sc-1931

Goat polyclonal

N-19

N-terminus

400

Liver hepatocytes

SantaCruz (SantaCruz, CA, USA)

HSP27

Sc-13132

Mouse monoclonal

F-4

Amino acids 32–108

400

Tonsilla

SantaCruz (SantaCruz, CA, USA)

PRDX2

WH007001

Mouse monoclonal

4E 10-2D2

Amino acids 1–199

100

Tonsilla

Sigma-Aldrich

NCF2

HPA006040

Rabbit polyclonal

PrEST

Full-length

150

Glandular epithelium of colon

Sigma-Aldrich

TPM4

WH000717

Mouse monoclonal

4E4-1D2

Full-length

200

Placenta, decidual tissue

Sigma-Aldrich

  1. Abbreviations: CIN=cervical intraepithelial neoplasia; FIGO=International Federation of Gynecologic Oncology; SCC=squamous cervical cancer; SCE=squamous cervical epithelial.